AngioDynamics' (ANGO) Auryon Atherectomy System leverages breakthrough technology to deliver treatment of PAD lesions and occlusions.
The integration of Synchrony to Accuray's (ARAY) Radixact System will ensure that the hospital teams can efficiently deliver precise radiation doses to tumors.
Sector ETF report for PBE
DexCom (DXCM) sets up registry to track outcomes of patients and healthcare professionals using CGM in hospitals.
Investor confidence is high on Avanos Medical (AVNS), thanks to solid prospects.
, /PRNewswire/ -- The recent pandemic, which has put a heavy toll on our economy and pushed the healthcare system into a severe scarcity problem, further illustrates the importance of medical devices...
OPKO Health (OPK) is developing its marketed drug, Rayaldee, as a potential treatment for patients with mild-to-moderate COVID-19.
OPKO Health (OPK) closed at $3.15 in the latest trading session, marking a -0.63% move from the prior day.
Investor confidence is high on Surmodics (SRDX) stock, thanks to solid prospects.
OPKO Health, Inc. (NASDAQ: OPK) announces the initiation of a Phase 2 trial with RAYALDEE as a treatment for mild-to-moderate COVID-19. The trial, "A Randomized, Double-Blind Placebo-Controlled Study...
, /PRNewswire/ -- As the pandemic continues to spread throughout the U.S., the need for testing is on the rise as well. Nevertheless, many states and regions are experiencing a shortage of tests, which...
Investor confidence is high on Allscripts (MDRX) stock, thanks to solid prospects.
Is (OPK) Outperforming Other Medical Stocks This Year?
Investor confidence is high on DaVita (DVA) stock, thanks to solid prospects.
HealthEquity (HQY) witnessed strong growth in Service, Custodial and Interchange segments in Q2.
Investor confidence is high on CONMED (CNMD) stock, thanks to solid prospects.
OPKO Health's (OPK) OnkoSight Advanced is a NGS assay that facilitates revolutionary DNA mutational profiling of tumor samples.
OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in two upcoming virtual investor conferences.
Baxter's (BAX) expanded HDx therapy delivered by Theranova becomes accessible for patients with kidney failure in the United States.
, /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today began testing principals, teachers and other staff for COVID-19, across the five boroughs, in preparation...